Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.52 -0.09 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Zentalis Pharmaceuticals (ZNTL) posted Net Equity Issued and Repurchased of $65,000 for Q2 2026, down 80.4% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Zentalis Pharmaceuticals was $5.6 million; for FY2025, it was $5.39 million.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -50.0% (FY2020 to FY2025).
  • In prior years, Zentalis Pharmaceuticals' Net Equity Issued and Repurchased was $349,000 in FY2024 (-99.9%), $235.68 million in FY2023 (-8.6%), $257.92 million in FY2022 (+50.0%) and $171.97 million in FY2021 (-0.3%).
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q2 2024.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q4 2022, with growth of 398.7%; the weakest was Q2 2024, with a decline of 100.0%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $331,000 (Q1 2026), $5.09 million (Q4 2025) and $115,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Zentalis Pharmaceuticals 187.05 Mn 187.05 Mn - 65,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65,000.00
Mar 31, 2026 331,000.00
Dec 31, 2025 5.09 Mn
Sep 30, 2025 115,000.00
Mar 31, 2025 189,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 9,000.00
Mar 31, 2024 248,000.00
Jun 30, 2023 235.31 Mn
Mar 31, 2023 373,000.00
Dec 31, 2022 48.63 Mn
Jun 30, 2022 208.04 Mn
Mar 31, 2022 1.26 Mn
Dec 31, 2021 9.75 Mn
Sep 30, 2021 162.15 Mn
Jun 30, 2021 70,000.00
Jun 30, 2020 158.25 Mn
Mar 31, 2020 14.23 Mn
API Access

Zentalis Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ZNTL&period=max&api_key=YOUR_API_KEY